105 related articles for article (PubMed ID: 3035480)
21. LATS in Graves' disease.
McKenzie JM; Zakarija M
Recent Prog Horm Res; 1976; 33():29-57. PubMed ID: 198858
[No Abstract] [Full Text] [Related]
22. Immunological aspects of Graves' disease and importance of thyroid stimulating immunoglobulins.
Bech K
Acta Endocrinol Suppl (Copenh); 1983; 254():3-38. PubMed ID: 6191508
[No Abstract] [Full Text] [Related]
23. Specific stimulation of Graves' disease thyrocytes by the natural anti-Gal antibody from normal and autologous serum.
Winand RJ; Devigne JW; Meurisse M; Galili U
J Immunol; 1994 Aug; 153(3):1386-95. PubMed ID: 8027563
[TBL] [Abstract][Full Text] [Related]
24. Detection of tsh binding inhibiting antibodies (TBI-ab) and thyroid adenylate cyclase stimulating antibodies (TS-ab) in sera of patients with Graves' disease.
Lattanzi V; Scardapane R; Ciampolillo A; Vincenti C; Giorgino R
Boll Soc Ital Biol Sper; 1985 Jan; 61(1):55-60. PubMed ID: 3838478
[TBL] [Abstract][Full Text] [Related]
25. [Human thyroid stimulator (HTS) in thyroid diseases].
Hu ZY
Zhonghua Nei Ke Za Zhi; 1984 Aug; 23(8):480-3, 525. PubMed ID: 6548953
[No Abstract] [Full Text] [Related]
26. The role of long-acting thyroid stimulator and of thyroid autoimmunity in the pathogenesis of euthyroid endocrine ophthalmopathy.
Földes J; Takó J; Bános C; Gesztesi E
Acta Med Acad Sci Hung; 1971; 28(2):171-9. PubMed ID: 5172524
[No Abstract] [Full Text] [Related]
27. Sensitive thyroid-stimulating antibody assay with high concentrations of polyethylene glycol for the diagnosis of Graves' disease.
Takasu N; Kamijo K; Sato Y; Yoshimura H; Nagata A; Ochi Y
Clin Exp Pharmacol Physiol; 2004; 31(5-6):314-9. PubMed ID: 15191404
[TBL] [Abstract][Full Text] [Related]
28. Xenogeneic thyroid-stimulating hormone-like activity of the human natural anti-Gal antibody. Interaction of anti-Gal with porcine thyrocytes and with recombinant human thyroid-stimulating hormone receptors expressed on mouse cells.
Winand RJ; Anaraki F; Etienne-Decerf J; Galili U
J Immunol; 1993 Oct; 151(7):3923-34. PubMed ID: 8104224
[TBL] [Abstract][Full Text] [Related]
29. The eye changes of Graves' disease: overview.
Werner SC
Mayo Clin Proc; 1972 Dec; 47(12):969-74. PubMed ID: 4564711
[No Abstract] [Full Text] [Related]
30. [Radioreceptor assay of TSH].
Torizuka K; Konishi J; Endo K; Ikekubo K; Mori T
Nihon Rinsho; 1976; 34(3):471-6. PubMed ID: 778435
[No Abstract] [Full Text] [Related]
31. Pathogenesis of neonatal Graves' disease.
McKenzie JM; Zakarija M
J Endocrinol Invest; 1978 Apr; 1(2):183-9. PubMed ID: 385703
[No Abstract] [Full Text] [Related]
32. Inactivation of human thyroid stimulator by human thyroid extract.
Shishiba Y; Takaishi M; Shimizu T
Endocrinol Jpn; 1979 Apr; 26(2):285-9. PubMed ID: 225166
[TBL] [Abstract][Full Text] [Related]
33. Partial characterization and clinical correlation of circulating human immunoglobulins directed against thyrotrophin binding sites in guinea pig fat cell membranes. Development of a direct enzyme immunoassay.
Baker JR; Lukes YG; Smallridge RC; Berger M; Burman KD
J Clin Invest; 1983 Oct; 72(4):1487-97. PubMed ID: 6138364
[TBL] [Abstract][Full Text] [Related]
34. Failure to detect long-acting thyroid stimulator with the immunofluorescence technique.
Fedder G; Feltkamp TE
Clin Exp Immunol; 1970 Jan; 6(1):167-8. PubMed ID: 4906525
[No Abstract] [Full Text] [Related]
35. The assay for thyroid stimulating immunoglobulin using cultured human thyroid cells and its clinical application.
Sun ML; Guo ZS; Bai Y; Dai WX; Zhang ZJ; Chi ZS
Sci Sin B; 1988 May; 31(5):585-9. PubMed ID: 2901786
[TBL] [Abstract][Full Text] [Related]
36. Letter: Immunoglobulin deposits on thyroid-cell surface in Graves' disease.
Khalid BA; Cauchi MN
Lancet; 1973 Nov; 2(7837):1090. PubMed ID: 4127349
[No Abstract] [Full Text] [Related]
37. Thyroid stimulating immunoglobulins. The Watson Smith lecture 1983.
Munro DS
J R Coll Physicians Lond; 1984 Jul; 18(3):155-60. PubMed ID: 6147408
[No Abstract] [Full Text] [Related]
38. Serum long acting thyroid stimulator protector in pregnancy complicated by Graves' disease.
Hardisty CA; Munro DS
Br Med J (Clin Res Ed); 1983 Mar; 286(6369):934-5. PubMed ID: 6403139
[TBL] [Abstract][Full Text] [Related]
39. Suppressibility of thyroid function despite high levels of long-acting thyroid stimulator.
Wong ET; Doe RP
Ann Intern Med; 1972 Jan; 76(1):77-84. PubMed ID: 4112158
[No Abstract] [Full Text] [Related]
40. Radioimmunological studies on the long-acting thyroid stimulator.
Pinchera A; Rovis L; Grasso L; Liberti P; Martino E; Fenzi GF; Baschieri L
Endocrinology; 1970 Aug; 87(2):217-25. PubMed ID: 4193237
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
